Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Gamified occupational therapy programme, Classic occupational therapy programme.
- Who it may be relevant to
- Registry conditions: Duchenne Muscular Dystrophy, Gamification, Occupational Therapy. Basic parameters: 13 years — 18 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This research aims to improve the quality of life, occupational performance, occupational satisfaction and emotional health of young people with Duchenne muscular dystrophy compared to the classical occupational therapy program. The findings are planned to shed light on the development of new and effective strategies in the rehabilitation of adolescents with Duchenne muscular dystrophy.
Interventions
- Other Gamified occupational therapy programme
Gamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks - Other Classic occupational therapy programme
Gamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks
Primary outcome measures
- Demographic information form [Time frame: At the start of the evaluations]
- Modified Mini Mental State Test [Time frame: before and after the eight-week intervention programs]
- Vignos lower extremity functional scale [Time frame: before and after the eight-week intervention programs]
- Brooke upper extremity functional classification scale [Time frame: before and after the eight-week intervention programs]
- The Pediatric Quality of Life Inventory 3.0 Neuromuscular Module [Time frame: before and after the eight-week intervention programs]
- Canadian Occupational Performance Measure [Time frame: before and after the eight-week intervention programs]
- Children's Depression Inventory [Time frame: before and after the eight-week intervention programs]
- The Pediatric Quality of Life Inventory Multidimensional Fatigue Scale [Time frame: before and after the eight-week intervention programs]
- The Numeric Rating Scale - Pain [Time frame: before and after the eight-week intervention programs]
Eligibility criteria
Inclusion criteria
- Being diagnosed with Duchenne muscular dystrophy
- To be literate in Turkish
- To have scored 27 points or more on the Modified Mini Mental Test
- Having a computer, tablet and internet connection
- Volunteering to participate in the study by their parents and reading and signing the informed consent form
Exclusion criteria
- Having a neurological disease other than Duchenne muscular dystrophy and/or another diagnosed neurological disease accompanying Duchenne muscular dystrophy
- Having a cooperation problem that prevents completing the assessments for any reason
- Difficulty understanding and speaking the Turkish language
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
Turkey (Türkiye) · 1 center
- Lokman Hekim University — Ankara
Publications
- Arslan BC, Sahin S. Gamified occupational therapy program for adolescents with Duchenne muscular dystrophy: A study protocol for randomized controlled trial. Assist Technol. 2026 Jul 30:1-9. doi: 10.1080/10400435.2026.2709162. Online ahead of print. PMID 42530145
Identifiers
NCT: NCT06402942 · LHU20241004 · LHÜ